A tiny molecule called bombesin links starfish and humans in appetite control, revealing a surprising evolutionary connection.

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Eli Lilly says it is a first-of-its-kind treatment for obesity, overweight, and type 2 diabetes that activates both GIP and ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...

Tony Murphy was a solid 20-a-day smoker. His attempts at quitting lasted at best days, often only hours, as his craving for a ...

A team of biologists at Queen Mary University of London has discovered that a neurohormone controlling appetite in humans has ...

A team of biologists at Queen Mary University of London has discovered that a neurohormone controlling appetite in humans has ...

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...

Eli Lilly has launched Mounjaro in India, a new once-weekly injectable drug for type 2 diabetes and weight management.

But so-called small molecule pills will at least be easier ... the same list price as Ozempic. Risinger said he expects orforglipron to be priced at a slight discount to Zepbound, which means ...